Until
Until (fka Cradle) is a moonshot company building a “pause button” for biology. Our near-term focus is organ-scale reversible cryopreservation: preserving donated organs at subzero temperatures without ice formation, then rewarming them uniformly for transplant. By solving this grand challenge, we’re laying the foundation for whole-body reversible cryopreservation, giving patients a bridge to future cures.
- Location
- San Francisco, United States, United States
- Founded
- 2020
- Category
- SaaS
- Funding
- VC-backed
- Team
- 11–50
Frequently asked questions
What does Until do?
Until (fka Cradle) is a moonshot company building a “pause button” for biology. Our near-term focus is organ-scale reversible cryopreservation: preserving donated organs at subzero temperatures without ice formation, then rewarming them uniformly for transplant. By solving this grand challenge, we’re laying the foundation for whole-body reversible cryopreservation, giving patients a bridge to future cures.
Where is Until based?
Until is based in San Francisco, United States, United States.
When was Until founded?
Until was founded in 2020.
How much has Until raised?
Until is vc-backed. Funding details have not been disclosed.
How Until would pitch themselves
○ Auto-generated01Target customer
Business teams looking for modern saas tooling — replacing legacy software or building net-new workflows in this category.
02Problem they solve
Until (fka Cradle) is a moonshot company building a “pause button” for biology. Our near-term focus is organ-scale reversible cryopreservation: preserving donated organs at subzero temperatures without ice formation, th… The category has historically been served by tools that miss the modern workflow this product is built around.
03Key differentiator
Until differentiates on developing reversible cryopreservation — focusing on a specific edge in this category vs. broader incumbents.
04Go-to-market strategy
Series-A scaling stage — building outbound sales motion, hiring first AEs, layering on customer success. Mix of PLG (where the product allows) + direct sales for higher-ACV deals.